Compare Indo Pureco Pratama Tbk. (IPPE) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indo Pureco Pratama Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Indo Pureco Pratama Tbk. trades at Rp14 (market cap 64.4B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| IPPE | SCPI | |
|---|---|---|
Market Cap | 64.4B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indo Pureco Pratama Tbk.
PT Indo Pureco Pratama Tbk ("the Company") was established based on Notarial Deed No. 839 dated March 20, 2019, by Joice Hapsari Fendrini, S.H., M.Kn., Notary in Subang. The Company started its commercial operations in March 2019. The Company has coconut flesh processing factory located at Balimbing, Sub-District Pagaden Barat, District Subang, West Java, Indonesia.
Read more on IPPE →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
